Managed Healthcare Executive March 12, 2025
A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome and obesity — and treat it.
Dermatologists need to venture beyond the traditional boundaries of their specialty to treat obesity and insulin resistance, the root cause of many skin conditions, according to Lindsey A. Bordone, M.D.
“Without addressing obesity, we’re leaving our patients partially treated,” Bordone said at a well-attended session on incorporating glucagon-like peptide 1 (GLP-1) drugs and another diabetes drugs into dermatologic practice at the 2025 annual meeting of the American Academy of Dermatology in Orlando, Florida.
Bordone suggested that dermatologists, rather than other specialists or primary care physicians, should play a lead role in diagnosing metabolic syndrome. “What I...
Today's Sponsors
Today's Sponsor